- $448.43m
- $443.03m
- $243.64m
- 94
- 42
- 79
- 83
R2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 144 | 163 | 167 | 205 | 244 |
Cost of Revenue | |||||
Gross Profit | 40.2 | 46.3 | 54 | 64.2 | 81.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 173 | 203 | 173 | 208 | 243 |
Operating Profit | -28.2 | -39.6 | -5.64 | -2.66 | 0.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -29.6 | -40.6 | -8.34 | -1.52 | 0.814 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29.9 | -40.6 | -8.71 | -1.7 | 0.633 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.9 | -40.6 | -8.71 | -1.7 | 0.633 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.6 | -41.3 | -9.37 | -2.37 | 0.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.32 | -0.435 | -0.154 | -0.022 | 0.033 |